tiprankstipranks
Ohki Health Care Holdings, Inc. (JP:3417)
:3417
Japanese Market
Want to see JP:3417 full AI Analyst Report?

Ohki Health Care Holdings, Inc. (3417) AI Stock Analysis

0 Followers

Top Page

JP:3417

Ohki Health Care Holdings, Inc.

(3417)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - Gpt-5.6Sol)
Rating:52Neutral
Price Target:
¥1,077.00
▼(-24.26% Downside)
Action:Reiterated
Date:08/19/26
The score is held back primarily by deteriorating cash flow (negative operating and free cash flow for two consecutive years) and weakened FY2026 profitability despite steady revenue growth. Technicals also weigh on the outlook with the stock trading below major moving averages and negative MACD. Valuation is relatively supportive with a moderate P/E and a ~2.8% dividend yield, but not enough to offset the financial and trend risks.
Positive Factors
Resilient Revenue Growth
Consistent top-line growth indicates durable demand for the company’s healthcare distribution services. Continued sales expansion across pharmacies, hospitals, clinics, and medical institutions supports scale and provides a foundation for future operating improvement.
Negative Factors
Weak Cash Generation
Two consecutive years of negative operating and free cash flow point to weak or volatile cash conversion, potentially from working-capital demands. This reduces financial flexibility and may constrain investment, debt reduction, or shareholder distributions.
Read all positive and negative factors
Positive Factors
Negative Factors
Resilient Revenue Growth
Consistent top-line growth indicates durable demand for the company’s healthcare distribution services. Continued sales expansion across pharmacies, hospitals, clinics, and medical institutions supports scale and provides a foundation for future operating improvement.
Read all positive factors

Ohki Health Care Holdings, Inc. (3417) vs. iShares MSCI Japan ETF (EWJ)

Ohki Health Care Holdings, Inc. Business Overview & Revenue Model

Company Description
Ohki Healthcare Holdings Co.,Ltd., a venerable Japanese enterprise founded in Tokyo in 1658, operates with a broad and diversified portfolio across numerous sectors. The company primarily engages in the import, export, distribution, and sale of an...
How the Company Makes Money
Ohki Health Care Holdings primarily makes money through wholesale distribution within Japan’s healthcare supply chain. The company purchases pharmaceuticals and other healthcare-related products from manufacturers and marketing authorization holde...

Ohki Health Care Holdings, Inc. Financial Statement Overview

Summary
Steady revenue growth supports the top line, but profitability weakened materially in FY2026 (operating profit and net income down sharply) and margins are thin. The biggest risk is cash generation: operating cash flow and free cash flow were negative in FY2025 and FY2026 after a strong FY2024, reducing flexibility alongside rising debt.
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
34
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue363.02B360.36B349.45B334.66B304.44B278.16B
Gross Profit17.15B17.24B18.19B16.89B15.58B13.42B
EBITDA391.00M1.17B3.16B2.42B2.44B981.00M
Net Income750.00M1.34B2.64B2.21B2.18B971.00M
Balance Sheet
Total Assets154.17B148.39B140.96B140.08B123.96B115.39B
Cash, Cash Equivalents and Short-Term Investments3.65B2.21B2.88B8.31B3.24B2.77B
Total Debt20.95B15.62B14.21B6.95B8.48B7.50B
Total Liabilities120.83B114.22B109.90B112.18B99.68B93.29B
Stockholders Equity33.34B34.16B30.99B27.84B24.13B21.95B
Cash Flow
Free Cash Flow0.00-2.74B-12.03B7.27B-138.00M1.22B
Operating Cash Flow0.00-1.42B-9.18B7.55B96.00M1.31B
Investing Cash Flow0.00-671.00M-3.13B-496.00M-291.00M68.00M
Financing Cash Flow0.001.42B6.89B-2.00B681.00M-1.40B

Ohki Health Care Holdings, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1422.00
Price Trends
50DMA
1102.78
Negative
100DMA
1173.42
Negative
200DMA
1270.42
Negative
Market Momentum
MACD
-15.95
Negative
RSI
45.04
Neutral
STOCH
29.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3417, the sentiment is Negative. The current price of 1422 is above the 20-day moving average (MA) of 1056.45, above the 50-day MA of 1102.78, and above the 200-day MA of 1270.42, indicating a neutral trend. The MACD of -15.95 indicates Negative momentum. The RSI at 45.04 is Neutral, neither overbought nor oversold. The STOCH value of 29.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3417.

Ohki Health Care Holdings, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥214.94B12.972.35%8.76%8.19%
70
Outperform
¥259.17B15.6010.75%1.20%12.20%-25.42%
69
Neutral
¥522.89B16.141.28%8.72%3.45%
64
Neutral
¥1.07T18.227.67%2.04%
54
Neutral
¥391.74B23.670.41%13.04%-0.05%
52
Neutral
¥14.59B18.801.83%2.87%-73.55%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3417
Ohki Health Care Holdings, Inc.
1,032.00
-250.73
-19.55%
JP:7649
Sugi Holdings Co
1,321.00
-515.26
-28.06%
JP:3391
TSURUHA Holdings
2,343.50
113.41
5.09%
JP:3148
Create SD Holdings Co., Ltd.
3,410.00
63.57
1.90%
JP:3349
COSMOS Pharmaceutical Corporation
6,524.00
-2,269.76
-25.81%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
4,196.00
339.64
8.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2026